Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Semler Scientific Inc. (SMLR : NSDQ)
 
 • Company Description   
Semler Scientific, Inc. is a medical risk-assessment company. The Company engages in developing, manufacturing, and marketing patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Its products include FloChec (R) which is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians. Semler Scientific, Inc. is headquartered in Portland, Oregon.

Number of Employees: 79

 
 • Price / Volume Information   
Yesterday's Closing Price: $45.53 Daily Weekly Monthly
20 Day Moving Average: 1,078,613 shares
Shares Outstanding: 13.69 (millions)
Market Capitalization: $623.21 (millions)
Beta: 1.39
52 Week High: $81.56
52 Week Low: $21.77
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 48.11% 43.04%
12 Week 40.16% 18.28%
Year To Date -15.68% -20.28%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
51 E Campbell Ave Suite 107-D
-
Campbell,CA 95008
USA
ph: 877-774-4211
fax: -
ir@semlerscientific.com http://www.semlerscientific.com
 
 • General Corporate Information   
Officers
Douglas Murphy-Chutorian - Chief Executive Officer and
Renae Cormier - Chief Financial Officer
Daniel S. Messina - Director
Eric Semler - Director
William H.C. Chang - Director

Peer Information
Semler Scientific Inc. (ABMD)
Semler Scientific Inc. (DMDS)
Semler Scientific Inc. (CPWY.)
Semler Scientific Inc. (EQUR)
Semler Scientific Inc. (ECIA)
Semler Scientific Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 81684M104
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 13.69
Most Recent Split Date: (:1)
Beta: 1.39
Market Capitalization: $623.21 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 13.51
PEG Ratio: -
Price Ratios
Price/Book: 2.70
Price/Cash Flow: 10.17
Price / Sales: 12.66
EPS Growth
vs. Year Ago Period: -197.44%
vs. Previous Quarter: -122.29%
Sales Growth
vs. Year Ago Period: -44.44%
vs. Previous Quarter: -28.82%
ROE
06/30/25 - -
03/31/25 - 19.75
12/31/24 - 34.63
ROA
06/30/25 - -
03/31/25 - 15.47
12/31/24 - 32.68
Current Ratio
06/30/25 - -
03/31/25 - 0.52
12/31/24 - 3.59
Quick Ratio
06/30/25 - -
03/31/25 - 0.51
12/31/24 - 3.54
Operating Margin
06/30/25 - -
03/31/25 - 55.79
12/31/24 - 72.65
Net Margin
06/30/25 - -
03/31/25 - -60.69
12/31/24 - 72.65
Pre-Tax Margin
06/30/25 - -
03/31/25 - -70.66
12/31/24 - 85.06
Book Value
06/30/25 - -
03/31/25 - 16.85
12/31/24 - 24.90
Inventory Turnover
06/30/25 - -
03/31/25 - 11.92
12/31/24 - 12.43
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.59
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 37.28
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©